Review

Bone Marrow Transplantation (2008) 41, 757–764; doi:10.1038/bmt.2008.3; published online 4 February 2008

Pain syndromes in the setting of haematopoietic stem cell transplantation for haematological malignancies

P Niscola1, C Romani2, L Scaramucci1, T Dentamaro1, L Cupelli1, A Tendas1, D Piccioni1, M Giovannini1, B Tolu1, C Cartoni3, E Arcuri4, A Perrotti1, R Palumbo5 and P de Fabritiis1

  1. 1Haematology Division, Sant'Eugenio Hospital, Tor Vergata University, Rome, Italy
  2. 2Department of Haematology and Transplant Centre, Armando Businco Cancer Centre, Cagliari, Italy
  3. 3Department of Human Biotechnology and Haematology, La Sapienza University, Rome, Italy
  4. 4Pain Clinic and Palliative Care Unit, Regina Elena National Cancer Institute, Rome, Italy
  5. 5Nephrology Unit, Sant'Eugenio Hospital, Rome, Italy

Correspondence: Dr P Niscola, Haematology Division, Sant'Eugenio Hospital, Tor Vergata University, Piazzale dell'Umanesimo 10, Rome 00144, Italy. E-mail: pasquale.niscola@uniroma2.it

Received 1 June 2007; Revised 10 December 2007; Accepted 10 December 2007; Published online 4 February 2008.

Top

Abstract

Severe pain syndromes may be recorded during all phases of haematopoietic stem cell transplantation (HSCT) for haematological malignancies: from stem cell mobilization to the long-term post transplant period. Although the major cause of pain in the setting of HSCT is injury to mucosal tissues induced by the conditioning regimen, pain from several other causes has been reported. In this paper, we review pain and its management in the setting of HSCT.

Keywords:

mucositis, haematopoietic stem cell transplantation, opioids, pain, morphine, patient-controlled analgesia

Extra navigation

.
ADVERTISEMENT